Shay Way Seng
Direktor/Vorstandsmitglied bei TauRx Pharmaceuticals Ltd.
Aktive Positionen von Shay Way Seng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
TauRx Pharmaceuticals Ltd.
 TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - | |
| Vorstandsvorsitzender | - | - |
Karriereverlauf von Shay Way Seng
Statistik
International
| Singapur | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
TauRx Pharmaceuticals Ltd.
TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | Health Technology |
- Börse
- Insiders
- Shay Way Seng
- Erfahrung
